US2017274212A1PendingUtilityA1
Selective stimulation to modulate the sympathetic nervous system
Individually held — no corporate assignee on recordPriority: Sep 8, 2004Filed: Nov 8, 2016Published: Sep 28, 2017
Est. expirySep 8, 2024(expired)· nominal 20-yr term from priority
A61N 1/0551A61N 1/36057A61N 1/36135A61N 1/36071A61N 1/36114
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Systems, methods and devices are provided for the targeted treatment of a variety of medical conditions by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies. Typically, the target anatomy includes one or more dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions thereof. Such target stimulation areas are utilized due in part to their effect on the sympathetic nervous system.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating myocardial ischemia in a patient by modulating a neural pathway in the sympathetic nervous system, comprising:
identifying myocardial ischemia in the patient; positioning at least one electrode in close proximity to a dorsal root ganglion of the patient upstream of at least one ganglion of the sympathetic nerve chain, wherein the dorsal root ganglion is located within T2 to T6 spinal segments; and treating myocardial ischemia in the patient by increasing blood flow in the coronary vascular system through provision of electrical pulses to the at least one electrode so as to directly neuromodulate the dorsal root ganglion in a manner that influences a condition associated with the at least one ganglion of the sympathetic nerve chain while excluding neuromodulation of an associated ventral root.Join the waitlist — get patent alerts
Track US2017274212A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.